Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,766.50
Bid: 1,766.00
Ask: 1,766.50
Change: 36.50 (2.11%)
Spread: 0.50 (0.028%)
Open: 1,735.50
High: 1,766.50
Low: 1,735.00
Prev. Close: 1,730.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BRIEFING: GSK settles Zantac litigation in California

Fri, 23rd Jun 2023 07:58

(Alliance News) - Stocks in London are set to open in the red on Friday, as risk sentiment across the globe is damped by hawkish central banks.

On Thursday, the Bank of England surprised with a chunkier-than-expected 50 basis point interest rate hike.

A 25 basis point hike had been largely expected. However, following Wednesday's red-hot consumer price index data, bets on a half-point hike had increased, with the expectation that a more aggressive move may better tame the UK's stubborn annual inflation rate.

Defying the otherwise gloomy mood, government data showed UK retail sales volumes held up better than expected in May, boosted by sunny weather. In addition, GfK's UK consumer confidence indicator ticked up, despite the cost-of-living crisis and double-digit grocery inflation.

In early UK company news, GSK said it has reached a confidential settlement in a lawsuit related to Zantac in California. HSBC downgraded stocks of blue-chip housebuilders, meanwhile.

Revolution Beauty boasted a 60% year-on-year increase in sales at the beginning of its financial year and continued to hit out at boohoo.

Here is what you need to know at the London market open:

----------

MARKETS

----------

FTSE 100: called down 18.8 points, 0.3%, at 7,483.23

----------

Hang Seng: down 1.9% at 18,850.50

Nikkei 225: closed down 1.5% at 32,781.54

S&P/ASX 200: closed down 1.3% at 7,099.20

----------

DJIA: closed down just 4.81 points at 33,946.71

S&P 500: closed up 16.20 points, or 0.4%, at 4,381.89

Nasdaq Composite: closed up 128.41 points, or 1.0%, at 13,630.61

----------

EUR: down at USD1.0932 (USD1.0953)

GBP: down at USD1.2706 (USD1.2741)

USD: up at JPY143.39 (JPY142.86)

Gold: up at USD1,915.28 per ounce (USD1,913.60)

Oil (Brent): down at USD73.47 a barrel (USD74.22)

(changes since previous London equities close)

----------

ECONOMICS

----------

Friday's key economic events still to come:

10:00 CEST EU flash PMI

09:15 CEST France flash PMI

09:30 CEST Germany flash PMI

09:00 CEST Spain GDP

09:00 CEST Switzerland balance of payments

09:30 BST UK flash PMI

12:00 BST UK BoE market participants survey results

07:30 EDT US Fed Atlanta President Raphael Bostic speaks

09:45 EDT US flash manufacturing PMI

09:45 EDT US flash services PMI

----------

Consumer confidence in the UK has climbed in June, despite red-hot inflation, amid growing optimism on personal finances. GfK's consumer confidence index increased three points to negative 24 in June, from a tally of negative 27 in May. It marks the fifth monthly improvement in-a-row. Despite "fierce economic headwinds", three measures were up, while one was down and one was unchanged. The index measuring changes in personal finances during the last 12 months was up five points on-month at minus 15, eight points better off a year prior. The general economic situation index during the last 12 months was unchanged monthly at minus 54. It was 11 points higher than in June 2022, however. The major purchase index, an indicator of confidence in buying big ticket items, was down one point to minus 25 in June, from minus 24 in May, however. It was =16 points higher than the same time last year.

----------

UK retail sales volumes held up better than expected in May, according to government data, boosted by sunny weather. The Office for National Statistics said retail sales fell 2.1% annually in May, easing from a downwardly revised fall of 3.4% in April. The market had been expecting a 2.6% fall for May, according to FXStreet-cited consensus. April's reading was previously reported as a 3.0% decline. From the previous month, sales ticked up 0.3% in May, slowing from a 0.5% rise in April. However, the reading was better than market consensus, which had forecast a 0.2% decline.

----------

BROKER RATING CHANGES

----------

JPMorgan places BHP and Rio Tinto on 'negative catalyst watch'

----------

HSBC cuts Berkeley Group to 'reduce' - price target 3,000 pence

----------

HSBC cuts Persimmon to 'hold' - price target 1,190 pence

----------

COMPANIES - FTSE 100

----------

GSK said it has reached a confidential settlement with James Goetz, a claimant in Zantac litigation. The case he filed in California state court, which was set to begin in July, will now be dismissed. "The settlement reflects the company's desire to avoid distraction related to protracted litigation in this case. GSK does not admit any liability in this settlement and will continue to vigorously defend itself based on the facts and the science in all other Zantac cases," the pharmaceutical company said.

----------

Shell and BP were among the fossil fuel companies named in a US lawsuit. A county in the northwestern state of Oregon on Thursday filed suit against major fossil fuel corporations seeking more than USD51 billion over the 2021 "Heat Dome", one of the US' deadliest ever weather disasters. Multnomah County, which encompasses the state's most populous city Portland, said combined historic carbon pollution from use of the companies' products – and their decision to mislead the public about their impacts – was a big factor in exacerbating the heat wave. Multnomah County's suit names major oil firms including ExxonMobil, Shell, Chevron and BP, but also the American Petroleum Institute and Western States Petroleum Association, trade groups, as well as consultancy McKinsey & Company.

----------

The UK Competition & Markets Authority said it was beginning a merger investigation into Severn Trent's buy of Andigestion. On Monday, the CMA had said it was considering whether the merger would create any lessening of competition in any UK markets, and invited interested parties to comment. Water utility Severn Trent had announced its green power unit's acquisition of Andigestion in February. Andigestion which operates two food waste anaerobic digestion plants in southwest England. It disclosed no financial details. The CMA said it has a deadline of August 18 for its phase 1 decision.

----------

OTHER COMPANIES

----------

Revolution Beauty hailed its recent trading, and took aim at boohoo for its recent "hostile" attempts to re-shape the embattled beauty company's board. Revolution Beauty said trading has been "excellent" in the first three months of the financial year ending February 28, with sales up 60% year-on-year, and gross margins improving to 48.2% from 41.7%. In recent days, online fast fashion retailer boohoo, which holds just under a 27% stake in Revolution, has attempted to replace the company's board. "boohoo's stated rationale for the proposed changes to the Revolution Beauty board is that the focus of the group must switch to growth. The company hopes that shareholders are reassured that the current board is similarly minded and that growth is being delivered without one shareholder taking control of the board at the expense of the interests of other shareholders," Revolution Beauty said. Among boohoo's latest proposed additions was Rachel Horsefield, former chief executive of THG Beauty, a company Revolution Beauty "has recently undertaken to cease commercial relationships" with. "The board of Revolution Beauty believes that boohoo's announcement yesterday vindicates its view," Revolution Beauty explained, affirming that members of its own board are better-placed to drive than company forward than those boohoo recommends.

----------

By Elizabeth Winter, Alliance News senior markets reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
1 Nov 2023 08:51

TOP NEWS: GSK ups guidance as boosted by Shingrix and Arexvy

(Alliance News) - GSK PLC on Wednesday hailed the performance of the world's first approved respiratory syncytial virus vaccine Arexvy, as it reported a rise in profit and revenue.

Read more
1 Nov 2023 08:50

LONDON MARKET OPEN: FTSE 100 up, FTSE 250 down as Aston Martin tumbles

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of key central bank decisions, as investors were cheered by some strong updates from large-cap listings.

Read more
1 Nov 2023 07:40

LONDON BRIEFING: GSK raises annual guidance following Arexvy launch

(Alliance News) - Stocks in London are called higher on Wednesday, with the main focal point for the day being the upcoming US interest rate decision.

Read more
1 Nov 2023 07:27

GSK hikes guidance after strong third quarter

(Sharecast News) - GSK announced a robust third quarter on Wednesday, prompting an upgrade to its full-year guidance.

Read more
30 Oct 2023 09:01

IN BRIEF: GSK says Jemperli meets endpoint in endometrial cancer trial

GSK PLC - Brentford, west London-based pharmaceutical maker - Jemperli, whose generic name is dostarlimab, meets endpoint of overall survival in phase III Ruby trial on adult patients with primary advanced or recurrent endometrial cancer. Jemperli, combined with standard-of-care chemotherapy, followed by dostarlimab, demonstrated a "statistically significant and clinically meaningful benefit" to the patients in the trial.

Read more
30 Oct 2023 07:06

GSK's Jemperli sees success in endometrial cancer trial

(Sharecast News) - GSK reported encouraging outcomes from part one of the 'RUBY' phase three trial evaluating the efficacy of 'Jemperli', or dostarlimab, with standard chemotherapy for treating adult patients with advanced or recurrent endometrial cancer on Monday.

Read more
26 Oct 2023 09:19

TOP NEWS: GSK subsidiary ViiV receives HIV drug approval in China

(Alliance News) - GSK PLC on Thursday said its subsidiary ViiV Healthcare has received marketing authorisation in China for its cabotegravir treatment, marketed as Vocabria.

Read more
26 Oct 2023 07:02

GSK HIV injection regimen gets approval in China

(Sharecast News) - GSK announced on Thursday that its majority-owned HIV specialist subsidiary ViiV has received approval from the National Medical Products Administration (NMPA) of China for an injection regimen.

Read more
25 Oct 2023 16:01

UK earnings, trading statements calendar - next 7 days

Thursday 26 October 
Bank of Ireland Group PLCTrading Statement
Bloomsbury Publishing PLCHalf Year Results
Botswana Diamonds PLCTrading Statement
C&C Group PLCHalf Year Results
e-Therapeutics PLCHalf Year Results
Financials Acquisition CorpTrading Statement
GCP Infrastructure Investments LtdTrading Statement
HarbourVest Global Private Equity LtdHalf Year Results
Hummingbird Resources PLCTrading Statement
Hunting PLCTrading Statement
Inchcape PLCTrading Statement
International Personal Finance PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Renishaw PLCTrading Statement
Standard Chartered PLCQ3 Results
Unilever PLCTrading Statement
WPP PLCTrading Statement
Friday 27 October 
International Consolidated Airlines Group SAQ3 Results
NatWest Group PLCQ3 Results
Monday 30 October 
Airtel Africa PLCHalf Year Results
Computacenter PLCTrading Statement
Glencore PLCTrading Statement
HSBC Holdings PLCQ3 Results
Lok'n Store Group PLCFull Year Results
Pearson PLCTrading Statement
Tuesday 31 October 
BP PLCQ3 Results
Coca-Cola HBC AGTrading Statement
Elementis PLCTrading Statement
essensys PLCFull Year Results
Georgia Capital PLCQ3 Results
Grit Real Estate Income Group LtdFull Year Results
RHI Magnesita NVTrading Statement
Spectris PLCQ3 Results
TP ICAP Group PLCTrading Statement
UP Global Sourcing Holdings PLCFull Year Results
Wednesday 1 November 
Asos PLCFull Year Results
Aston Martin Lagonda Global Holdings PLCQ3 Results
Beximco Pharmaceuticals LtdFull Year Results
GSK PLCQ3 Results
Next PLCTrading Statement
Smurfit Kappa Group PLCTrading Statement
Weir Group PLCTrading Statement
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
25 Oct 2023 09:35

GSK says RSV jab shows promising response in adults aged 50 to 59

(Alliance News) - GSK PLC on Wednesday said a trial found its respiratory syncytial virus vaccine Arexy delivered an immune response in adults aged 50 to 59.

Read more
25 Oct 2023 07:27

GSK hails success in US RSV vaccine trial

(Sharecast News) - Pharma giant GSK has announced positive preliminary results from a trial of its Arexvy vaccine to treatment respiratory syncytial virus (RSV) disease for a younger patient population in the US.

Read more
16 Oct 2023 08:09

TOP NEWS: GSK receives positive EU opinion on Jemperli for cancer

(Alliance News) - GSK PLC on Monday said its monoclonal antibody Jemperli is closer to becoming the first new frontline treatment option in the EU in decades for a certain form of endometrial cancer.

Read more
16 Oct 2023 07:44

LONDON BRIEFING: Hipgnosis pulls interim dividend on lower royalties

(Alliance News) - The FTSE 100 is likely to open higher on Monday, benefitting from higher oil and gas prices, while fears of escalating regional conflict in the Middle East damp risk sentiment elsewhere.

Read more
16 Oct 2023 07:16

GSK nears green light for Jemperli usage in Europe

(Sharecast News) - Pharma giant GSK has announced that European experts recommended the approval of its Jerperli drug for the treatment of a specific type of endometrial cancer - paving the way for marketing authorisation by the continent's regulatory body.

Read more
11 Oct 2023 11:51

GSK settles California Zantac lawsuit

(Sharecast News) - GSK has agreed to settle another lawsuit concerning its discontinued heartburn treatment Zantac, the drugs giant confirmed on Wednesday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.